Table of Contents

Key Takeaways

  • The Consolidated Appropriations Act 2026 extends Medicare telehealth flexibilities through December 31, 2027, and the Acute Hospital Care at Home waiver program through September 30, 2030.
  • The law introduces pharmacy benefit manager (PBM) reforms affecting both Medicare Part D and employer-sponsored group health plans.
  • The Medicare GLP-1 Bridge, launching July 1, 2026, gives eligible Part D beneficiaries access to certain GLP-1 weight-loss drugs for a $50 copay. This operates outside the standard Part D benefit flow.

Why the Consolidated Appropriations Act Matters to Insurance Agencies

The Consolidated Appropriations Act regularly introduces new regulations that shape healthcare policy and how your clients navigate the insurance landscape. The 2026 edition brings significant changes, especially as it relates to pharmacy benefit managers (PBMs) and access to GLP-1 drugs. 

More specifically, the 2026 Act includes:

  • Medicare telehealth extensions
  • Extending hospital-at-home waivers
  • Broad pharmacy benefit manager (PBM) reforms affecting both Medicare Part D and ERISA-governed employer plans
  • Medicare Advantage provider directory accuracy requirements
  • New frameworks for prescription drug access — especially for GLP-1 drugs

For health, benefits, and senior insurance agencies, that translates directly into changed client expectations, new compliance considerations, and more questions landing in your inbox. Let’s dive further into the legislation to highlight the changes your agency should pay attention to.

Organized Data = Easier Compliance Management

When your agency’s data is in one central place, adapting to regulatory changes becomes much easier. Request a demo with the AgencyBloc team to see how data organization is possible with AMS+!

Schedule a 1:1 Demo

3 Key Consolidated Appropriations Act Changes Agents Should Watch

1. Medicare Telehealth Flexibilities Continue to Evolve

The 2026 legislation extends Medicare telehealth flexibilities through December 31, 2027. These extensions were originally pandemic-era measures, but have now expanded further to cover:

  • Home-based services
  • Audio-only visits
  • Continued access to federally qualified health centers (FQHCs) 
  • Continued access to rural health clinics as telehealth sites

These extensions are an indicator of just how rooted telehealth access has become in the United States — especially for Medicare beneficiaries. For senior market agents, this means your clients will be asking about virtual care options and have expectations for access to them.

Agent Takeaways

  • Confirm plan-specific telehealth rules during every enrollment conversation. Note: Not all Medicare Advantage plans offer the same virtual care options.
  • Track client preferences for virtual vs. in-person care in the client’s record in your agency management system (AMS) or CRM.
  • Document coverage explanations and any telehealth-related follow-ups directly in the policy file.

2. Medicare Hospital-at-Home & In-Home Care Provisions May Shape Client Expectations

The Consolidated Appropriations Act of 2026 extends the Acute Hospital Care at Home (AHCAH) waiver initiative through September 30, 2030. More than 400 hospitals used these waivers last year to provide acute-level care in patients’ homes. The law also allows certain cardiopulmonary rehabilitation services to be provided via telehealth at a beneficiary’s home in 2026 and 2027.

What does this mean for agents? Seniors are paying attention. More clients will ask whether their Medicare plan supports home-based care, remote monitoring, and/or post-acute recovery services. To make answering these questions easier, keep plan documents, carrier communications, and notes easily accessible in your AMS or CRM.

3. PBM Reform Keeps Prescription Drug Costs in the Spotlight

If you’re a group benefits broker, PBM reforms in the Consolidated Appropriations Act 2026 are what you need to pay attention to. The CAA includes significant pharmacy benefit manager (PBM) reforms affecting both Medicare Part D and group health plans, as well as carriers offering group health insurance coverage.

Going further in depth, the reforms mean:

  • PBMs serving employer-sponsored group health plans must pass on 100% of all rebates, fees, and alternative discounts to the plans and issuers.
  • PBMs must provide group health plans with detailed prescription drug spending data at least twice per year, or quarterly if requested.
  • In Medicare Part D, PBM compensation can no longer be tied to list prices and rebates. This change indicates a move for the industry toward flat administrative fees.
  • Rebate pass-through requirements apply to plan years beginning on or after August 3, 2028.

These reforms are part of a larger movement within the industry toward increased transparency and employer accountability. As prescription drug spending data becomes more accessible, employers may face more scrutiny around vendor selection, plan governance, and documentation of benefit decisions.

Taking time to understand these reforms and others listed in the recent One Big Beautiful Bill and CMS Final Rule 2027 can give your team the confidence to answer your clients’ questions and better prepare for the upcoming enrollment season.

Agent Takeaways

  • Know which questions belong to you, which belong to the third-party administrator (TPA) or PBM, and which require legal counsel.
  • Keep renewal notes, plan documents, carrier communications, and employer decisions organized and accessible.
  • Use consistent workflows to track PBM-related follow-ups and compliance conversations so nothing falls through the cracks.
  • It may be worth communicating to your employer groups the importance of monitoring affordability thresholds, reporting requirements, and the potential impact of rising pharmacy costs on their overall health plan strategy.

Where GLP-1 Drugs Fit Into the 2026 Conversation

GLP-1 weight loss drugs are currently surging in popularity. These medications, including Wegovy, Zepbound, and Ozempic, have become one of the most frequently asked-about drug categories across the board — including under 65, group benefits, and the over 65 markets. They intersect with diabetes management, cardiovascular risk, obesity treatment, prior authorization, and affordability, creating real complexity for clients and agents alike.

CMS announced the Medicare GLP-1 Bridge, a “short-term demonstration” that begins July 1, 2026, and runs through December 31, 2027. The program is designed to provide eligible Part D beneficiaries with access to certain GLP-1 drugs while CMS develops a longer-term pathway through the BALANCE model.

What Agents Should Know About GLP-1 Client Questions

It is critical for agents to have answers to questions about GLP-1 drugs because your clients will be asking about them this enrollment season. 

For senior insurance agents, it’s important to note that the Bridge program is not standard Part D formulary coverage. It operates outside the normal Part D benefit flow, and CMS is using a single central processor — Humana — to handle prior authorizations, claims adjudication, and pharmacy payment.

Key facts senior insurance agents should have ready before enrollment season arrives:

  • Eligible drugs currently include Wegovy (injection and tablets), Zepbound, and Foundayo when prescribed for weight loss.
  • Beneficiaries pay a flat $50 copay per monthly fill.
  • That $50 does not count toward Part D TrOOP (true out-of-pocket costs), because the program operates outside the standard Part D benefit.
  • Eligibility is based on clinical criteria, like BMI and related conditions, that must be attested by the prescribing provider at the time therapy is initiated.
  • Beneficiaries must be enrolled in a Part D PDP or MA-PD plan for calendar year 2026 to qualify.

For your employer group and individual market clients, the coverage picture is more complicated. There is currently no broad federal mandate requiring employer-sponsored plans to cover GLP-1 drugs for weight loss under ERISA or the ACA. Currently, coverage varies widely from plan to plan.

Here’s what group benefits brokers need to know:

  • Many plans that exclude GLP-1s for weight loss still cover them when prescribed for type 2 diabetes or cardiovascular risk reduction. Knowing the plan’s formulary and exclusion language is crucial.
  • Self-funded plans have more flexibility but also more financial liability. Self-insured employers can decide whether and how to cover GLP-1s within the ERISA and ACA framework. With PBM reforms now requiring 100% rebate pass-through, employers may need to decide whether GLP-1 coverage makes economic sense at renewal.
  • Some employers are exploring excepted benefit HRAs (EBHRAs) to help cover GLP-1 costs outside the primary plan. But this option is very compliance-sensitive, so make sure to do your research before advising clients on this option.
  • GLP-1 coverage is becoming a larger part of the employee recruitment and retention conversation. According to Mercer, 77% of large employers say managing GLP-1 costs is extremely or very important in 2026.

Agent Takeaways

  • Avoid overpromising coverage. For Medicare clients, the Bridge program has specific eligibility criteria. For group clients, coverage depends entirely on the employer’s plan.
  • Confirm whether the drug is being used for diabetes, cardiovascular risk reduction, weight management, sleep apnea, or other conditions. This can affect coverage.
  • Document the plan, drug, prior authorization status, and any follow-up steps in the client record in your AMS or CRM.
  • Encourage clients to work directly with their provider and plan for clinical and coverage determinations.

What the Consolidated Appropriations Act Means for Day-to-Day Agency Operations

Every legislative change creates a ripple across your agency’s operations. The CAA 2026 is no exception. Between telehealth coverage questions, GLP-1 access inquiries, PBM reform conversations with employer groups, and Medicare plan comparisons, the volume of client-specific data your team is managing is growing.

Here’s a list of what your team should  track right now as it relates to the 2026 CAA:

  • Which clients asked about GLP-1 drugs and what was discussed
  • Which employer groups raised PBM-related questions at renewal
  • Which Medicare clients rely on telehealth or home-based care
  • Which renewals require additional documentation or compliance steps
  • Which agents need follow-up reminders for licensing or regulatory tasks
  • Which carrier updates have been received and actioned

Scattered Spreadsheets Make Compliance Harder

When client information lives across inboxes, spreadsheets, sticky notes, and individual producer files, the risk of missed follow-ups and lost documentation goes up. Not because your team is careless, but because the system isn’t built for this level of complexity.

The more layered health and Medicare policy becomes, the more your agency needs centralized operations. You can either walk into a renewal conversation prepared or scrambling to pull together notes from three different places.

Are Compliance Woes Slowing You Down?

It’s normal to be concerned about compliance, especially when your plate is already full. Find out how centralizing your data with the help of technology can be a game-changer for your agency.

Learn More

How AgencyBloc Helps Agencies Stay Organized Through Regulatory Change

The Consolidated Appropriations Act 2026 is a clear signal: health insurance policy, Medicare coverage, prescription drug access, and employer group compliance expectations will keep evolving. This isn’t brand new information, but rather confirmation that this will continue for the near future. Agents who stay organized will be better positioned to educate clients, document conversations, and respond when rules change.

That’s exactly what AgencyBloc’s Plus Suite is built for. AMS+, an AgencyBloc solution, gives health, benefits, and senior insurance agencies one place to manage prospects, clients, policies, carriers, agents, tasks, and compliance workflows. No repurposed CRM and no scattered spreadsheets.

Technology isn’t just an efficiency tool. For agencies serving the health, benefits, and senior markets, it’s an operational foundation. The more complex your clients’ questions become, the more it matters that your agency has a single place to track, document, and act on all of it.

Ready to Keep Your Agency's Data Connected?

See how AgencyBloc solutions help health, benefits, and senior insurance agencies stay organized, compliant, and ready for what comes next.

Request a Free Demo

Posted by Sarah Rosonke on Friday, June 12, 2026 in Electronic Compliance Management

  1. compliance management
  2. data management
  3. industry news
  4. open enrollment

About The Author

Sarah Rosonke

Sarah is the Design and Content Specialist at AgencyBloc. She creates and designs helpful resources to support life and health insurance agencies in growing and automating their business. Favorite quote: "You'll never do a whole lot unless you're brave enough to try." —Dol ... read more